- Home
- ASPN vs RLAY Comparison
ASPN vs RLAY Comparison
Compare ASPN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- RLAY
- Stock Information
- Founded
- ASPN 2001
- RLAY 2015
- Country
- ASPN United States
- RLAY United States
- Employees
- ASPN N/A
- RLAY N/A
- Industry
- ASPN RETAIL: Building Materials
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASPN Consumer Discretionary
- RLAY Health Care
- Exchange
- ASPN Nasdaq
- RLAY Nasdaq
- Market Cap
- ASPN 1.1B
- RLAY 1.1B
- IPO Year
- ASPN 2014
- RLAY 2020
- Fundamental
- Price
- ASPN $12.60
- RLAY $4.45
- Analyst Decision
- ASPN Strong Buy
- RLAY Strong Buy
- Analyst Count
- ASPN 10
- RLAY 10
- Target Price
- ASPN $30.80
- RLAY $20.11
- AVG Volume (30 Days)
- ASPN 1.8M
- RLAY 2.6M
- Earning Date
- ASPN 02-10-2025
- RLAY 11-06-2024
- Dividend Yield
- ASPN N/A
- RLAY N/A
- EPS Growth
- ASPN N/A
- RLAY N/A
- EPS
- ASPN 0.02
- RLAY N/A
- Revenue
- ASPN $413,830,000.00
- RLAY $10,006,000.00
- Revenue This Year
- ASPN $92.34
- RLAY N/A
- Revenue Next Year
- ASPN $10.74
- RLAY N/A
- P/E Ratio
- ASPN $649.19
- RLAY N/A
- Revenue Growth
- ASPN 93.28
- RLAY N/A
- 52 Week Low
- ASPN $10.75
- RLAY $4.25
- 52 Week High
- ASPN $33.15
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- ASPN 39.46
- RLAY 39.07
- Support Level
- ASPN $12.68
- RLAY $4.41
- Resistance Level
- ASPN $14.53
- RLAY $5.03
- Average True Range (ATR)
- ASPN 0.68
- RLAY 0.31
- MACD
- ASPN 0.15
- RLAY 0.05
- Stochastic Oscillator
- ASPN 28.75
- RLAY 20.65
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).